DK1196188T3 - VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser - Google Patents

VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser

Info

Publication number
DK1196188T3
DK1196188T3 DK00947514T DK00947514T DK1196188T3 DK 1196188 T3 DK1196188 T3 DK 1196188T3 DK 00947514 T DK00947514 T DK 00947514T DK 00947514 T DK00947514 T DK 00947514T DK 1196188 T3 DK1196188 T3 DK 1196188T3
Authority
DK
Denmark
Prior art keywords
vgf
treatment
monoclonal antibodies
related disorders
selective monoclonal
Prior art date
Application number
DK00947514T
Other languages
English (en)
Inventor
Hai Yan
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK1196188T3 publication Critical patent/DK1196188T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK00947514T 1999-07-21 2000-07-19 VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser DK1196188T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14474399P 1999-07-21 1999-07-21

Publications (1)

Publication Number Publication Date
DK1196188T3 true DK1196188T3 (da) 2005-11-07

Family

ID=22509932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00947514T DK1196188T3 (da) 1999-07-21 2000-07-19 VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser

Country Status (11)

Country Link
EP (1) EP1196188B1 (da)
JP (1) JP2003505428A (da)
AT (1) ATE298244T1 (da)
AU (1) AU779614B2 (da)
CA (1) CA2378845A1 (da)
DE (1) DE60020970T2 (da)
DK (1) DK1196188T3 (da)
ES (1) ES2244456T3 (da)
MX (1) MXPA02000678A (da)
PT (1) PT1196188E (da)
WO (1) WO2001007074A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002082075A2 (de) * 2001-04-06 2002-10-17 Biovision Ag Verfahren zum nachweis chronisch-demenzieller erkrankungen, zugehörige peptide und nachweisreagenzien
US7749716B2 (en) * 2004-05-18 2010-07-06 Vermilllion, Inc. Methods of detecting a fragment of neurosecretory protein VGF for diagnosing alzheimer's disease
US20100040621A1 (en) * 2005-04-27 2010-02-18 Takeda Pharmaceutical Company Limited Novel polpeptide and use thereof
JPWO2007013586A1 (ja) * 2005-07-29 2009-02-12 協和発酵キリン株式会社 新規ペプチド
GB201201332D0 (en) * 2012-01-26 2012-03-14 Imp Innovations Ltd Method

Also Published As

Publication number Publication date
AU6110300A (en) 2001-02-13
WO2001007074A1 (en) 2001-02-01
PT1196188E (pt) 2005-10-31
DE60020970T2 (de) 2006-05-11
CA2378845A1 (en) 2001-02-01
EP1196188A1 (en) 2002-04-17
ES2244456T3 (es) 2005-12-16
AU779614B2 (en) 2005-02-03
DE60020970D1 (de) 2005-07-28
ATE298244T1 (de) 2005-07-15
EP1196188B1 (en) 2005-06-22
MXPA02000678A (es) 2002-07-02
JP2003505428A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
DE60039752D1 (de) Herstellung tetravalenter antikörper
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
DE60028970D1 (de) An her2 bindende peptidverbindungen
AU2002305450A1 (en) Proteomimetic compounds and methods
FI963101A0 (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
HUP0301789A2 (hu) Rekombináns anti CD40 ellenanyagok és használatuk
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
DK2077279T3 (da) Tymiske stromale lymfopoietinreceptormolekyler og anvendelser heraf
TW200640944A (en) VGF polypeptides and methods of treating VGF-related disorders
WO2001070977A3 (en) Fibroblast growth factor receptor-like molecules and uses thereof
DE60228073D1 (de) Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen
WO2001079164A3 (en) N-substituted dithiocarbamates for the treatment of biological disorders
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
ATE235551T1 (de) Ligand (tie ligand-4) vom tie-2 rezeptor und dessen verwendungen
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
WO2002000723A3 (en) Thymic stromal lymphopoietin receptor molecules and uses thereof
DK1196188T3 (da) VGF-selektive monoklonale antistoffer og deres anvendelse til behandling af VGF-relaterede lidelser
TR200200278T2 (tr) Kalsilitik bileşimler
WO2004083241A3 (en) Btc-interacting proteins and use thereof
WO2003055980A3 (en) Il-17 like molecules and uses thereof
WO2001072334A3 (en) Methods for treating disease with antibodies to cxcr3